CLINICAL_TRIALS
trial_result
· 2013-10-24
Clinical Trial Update: Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery [Phase 2]
Summary
Phase 2 study evaluating GBT009 for treating incisional wounds after breast reconstruction; trial completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Garnet BioTherapeutics, Inc. | Conditions: Scar Formation | Phase 2 | Status: COMPLETED | Results posted: 2013-10-24